COBAS AMPLIPREP / COBAS TAQMAN HIV-1 TEST 03542998190

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 05 report with the FDA on 2011-03-21 for COBAS AMPLIPREP / COBAS TAQMAN HIV-1 TEST 03542998190 manufactured by Roche Molecular Systems.

Event Text Entries

[1914129] A customer site in the united states has been releasing test results from invalid test runs while using the cobas ampliprep / cobas taqman hiv-1 test version 1. The customer specified that they load two sets of controls on each run. If one set of controls is valid the customer uses this to release the results. As per the product labeling, the test run should have been invalidated and repeated. It is unknown whether any of the invalid results were inaccurate and/or lead to an incorrect patient treatment decision/change.
Patient Sequence No: 1, Text Type: D, B5


[9220915] As per the product labeling, customers are instructed that the negative and positive controls must be included with each test run. If either control is invalid, the customer must repeat the entire process (specimen and control preparation, amplification, and detection). As reported by the customer, patient results that were generated within a test run that contained an invalid control were reported. This is an off-label practice that may result in the release of erroneous, but believable, results. A definitive conclusion cannot be drawn at this time, as the investigation into this issue is ongoing. The outcome of this investigation will be communicated through a follow-up report. (b)(4).
Patient Sequence No: 1, Text Type: N, H10


[9257953] In the initial report, all conclusions were made. The following statement was incorreclty included in the initial report:"a definitive conclusion cannot be drawn at this time, as the investigation into this issue is ongoing. The outcome of this investigation will be communicated through a follow-up report. "the intital report was both the initial and final report. There will not be any follow up reports to the initial report. (b)(4).
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number2243471-2011-00037
MDR Report Key2025233
Report Source05
Date Received2011-03-21
Date of Report2011-03-02
Date of Event2011-01-31
Date Mfgr Received2011-03-02
Device Manufacturer Date2010-09-23
Date Added to Maude2012-01-06
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactVINCENT STAGNITTO
Manufacturer Street1080 US HWY 202S
Manufacturer CityBRANCHBURG NJ 088763733
Manufacturer CountryUS
Manufacturer Postal088763733
Manufacturer Phone9082537569
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameCOBAS AMPLIPREP / COBAS TAQMAN HIV-1 TEST
Generic NameTEST, HIV DETECTION
Product CodeMTL
Date Received2011-03-21
Catalog Number03542998190
Lot NumberN11742
Device Expiration Date2011-09-30
Device AgeDA
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerROCHE MOLECULAR SYSTEMS
Manufacturer Address1080 US HW 202S BRANCHBURG NJ 08876373 US 08876 3733


Patients

Patient NumberTreatmentOutcomeDate
10 2011-03-21

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.